Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368653 · ClinicalTrials.gov registry record · NA
Evaluation of Learning-Theory-Based Smoking Cessation Strategies
A NA study of Nicotine Dependence, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT01368653: Completed NA study of Nicotine Dependence, sponsored by Rutgers University.
NCT01368653 is a NA study of Nicotine Dependence that has completed, run by Rutgers University. The registered enrollment target is 93 participants, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01368653, a NA study of Nicotine Dependence, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tested whether a new treatment designed to help smokers prepare to quit smoking by practicing quitting several times helped more smokers quit and stay quit than standard treatment with nicotine patch and smoking cessation counseling. The practice quitting treatment tested involved quitting for progressively longer periods of time tailored to individual patterns of smoking. This clinical trial also tested whether non-nicotine cigarettes can help smokers become smoke free after slipping during a stop smoking attempt.
Primary Outcome
7-day point prevalence abstinence captures whether participants have used tobacco in the past 7 days at the 4-week post-quit follow-up (i.e., whether any tobacco use occurred in the 4th week of the quit attempt).
Conditions Studied
Interventions
- BEHAVIORAL Standard treatment
- BEHAVIORAL Standard treatment+practice quitting
- DRUG Very low nicotine cigarettes
Study Locations (1)
New Jersey
- Rutgers University Institute for Health, Health Care Policy, and Aging Research - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01368653 record still lists
NCT01368653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Standard treatment is the first listed.
NCT01368653 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01368653 about?
NCT01368653 is a clinical study titled "Evaluation of Learning-Theory-Based Smoking Cessation Strategies". This clinical trial tested whether a new treatment designed to help smokers prepare to quit smoking by practicing quitting several times helped more smokers quit and stay quit than standard treatment with nicotine patch and smoking cessation counseling. The practice quitting treatment tested involve...
What is the current status of trial NCT01368653?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2012-06. Estimated completion is 2013-08.
What conditions does trial NCT01368653 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT01368653?
The interventions under investigation include: Standard treatment (BEHAVIORAL), Standard treatment+practice quitting (BEHAVIORAL), Very low nicotine cigarettes (DRUG).
Who is sponsoring clinical trial NCT01368653?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01368653 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01368653's enrollment target sits among peer trials
93 36th of 67 higher than 32 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia